IGVFFI0249CBTP

preview
validated
This object is in preview status. Metadata is subject to change until this object is released.
File Set
IGVFDS6874YIXA(prime editing Variant-EFFECTS)
Summary
R2 reads from sequencing run 1
File Format
fastq
Content Type
reads
Aliases
jesse-engreitz:Jurkat_Stim-IL2RA_prom-NegControl-PCRRep1_R2
md5sum
9f9b684dd8264fca0e8366938b3658cd
Content MD5sum
c7fcdf26887052891369c7395e1abbc7
File Size
6.7 KB
Submitted File Name
Jurkat_Stim-IL2RA_prom-BioRep2-FFRep3-PCRRep1-BinNeg_S193_R2_001.fastq.gz

Sequencing Details

Sequencing Platform
Sequencing Run
1
Illumina Read Type
R2
Index
CGTTACCA:CCTG
Average Read Length
150
Read Count
47

Samples

1 item
Accession
Type
Sample Terms
Summary
InVitroSystem
Jurkat cell line, male, Homo sapiens treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2)

Files Derived From This File

1 item
Accession
File Format
Content Type
Summary
Lab
File Size
Upload Status
tsv
variant effects
variant effects
Jesse Engreitz, Stanford
5.9 KB
validated

Attribution